FDA Warning Streak Continues, Underscoring Risky Products And Claims

Agency has been turning up the heat this summer on skin-care marketers, posting two more July warning letters issued to companies for use of unapproved drug claims. Firms that sell anti-aging serums, eye-area formulas or anything promoted as an “anti-wrinkle” solution should review their claims to ensure compliance.

Add Sircuit Cosmeticeuticals Inc. and Sevani Botanica to the list of skin-care marketers served with FDA warning letters in 2016 for unapproved drug claims.

July 19 warning letters addressed to Sircuit President Michael Wolfgeher and Sevani founder Sheryl Gibbs must be answered within 15...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from United States

More from North America